Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
FY.3.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.12NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FR.1.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.16.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.4.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FR.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HH.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.22.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GY.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HW.1.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FY.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.38NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.16.12NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.46NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GB.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.72NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EG.10.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.41.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GW.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JG.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GJ.1.2.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.33.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EG.4.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JJ.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HK.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GK.3.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FR.1.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.10NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HK.12NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HK.33NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GK.5.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XCZNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.40NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GK.1.6.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-16939.3Singapore
GY.8NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XCWNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GA.2.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GK.1.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FY.4.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.103NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HC.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FE.1.1.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.94NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GK.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.15.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GJ.5.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.21NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.70NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GJ.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JG.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used